Asset Dedication LLC’s Integra LifeSciences IART Stock Holding History

Asset Dedication LLC’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-406	Closed	-$14K	–	1209
2024 Q1	$14K	Hold	406	–	–	﹤0.01%	642
2023 Q4	$18K	Hold	406	–	–	﹤0.01%	592
2023 Q3	$16K	Hold	406	–	–	﹤0.01%	601
2023 Q2	$17K	Hold	406	–	–	﹤0.01%	586
2023 Q1	$23K	Hold	406	–	–	﹤0.01%	532
2022 Q4	$23K	Buy	+406	New	+$20.7K	﹤0.01%	523

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Asset Dedication LLC's IART Position: Q2 2024 in Review

Asset Dedication LLC sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 406 shares — an estimated $14K sold.

Asset Dedication LLC first reported a position in IART in Q4 2022 and held it in 6 quarters. The position peaked at $23K in Q1 2023. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

Asset Dedication LLC reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
Asset Dedication LLC sold 406 Integra LifeSciences shares in Q2 2024, an estimated $14K.
Asset Dedication LLC first reported a position in Integra LifeSciences in Q4 2022 and held it in 6 quarters.
Asset Dedication LLC's Integra LifeSciences position peaked at $23K in Q1 2023.
238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Asset Dedication LLC's 13F filing for Q2 2024, filed 6 Aug 2024.